Stocks
Alnylam Pharmaceuticals (ALNY) EV/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EV/EBITDA | ? | -28.2 | 0.94 | 4.39 | -168.2 | 79.9 | 57.4 | |
| Changes by years, y/y, % | +53% | -103% | +367% | -3 931% | -148% | |||
Alnylam Pharmaceuticals. EV/EBITDA
Alnylam Pharmaceuticals. EV/EBITDA, changes, %
Alnylam Pharmaceuticals (ALNY) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EV/EBITDA | ? | -246.7 | 313.7 | 80.7 | 45.7 | 33.1 | 57.4 | |
| Changes by years, y/y, % | -36 806% | -216% | -148% | -120% | -113% | |||
| Changes by quarters, q/q, % | +7% | -227% | -74% | -43% | -28% | |||
